Kurma Partners

Biotech

Co-investorsSOSofinnova PartnersJOJohnson & Johnson Innovation – JJDCM M VenturesSRSR One Capital ManagementEQEQT Life Sciences

BliNK Biomedical develops treatments and therapeutics in the biopharmaceutical industry.

BiotechDeep TechMedical DevicesMarseille, FR

JEJack Elands(CEO & Chairman)

Co-investorsIDIdinvest Partners

Brink Therapeutics is a TechBio company developing programmable integrases, a nuclease-free platform for precise, large-payload genomic insertion of therapeutic genes for cell and gene therapy.

AI & Machine LearningBiotechDeep TechParis, FR

JNJonathan Naccache(Co-founder (Directeur de la publication))in

Co-investorsKIKima VenturesBRBreega

Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity.

BiotechDigital HealthHealthtechLongevity

PJPhilip JaniakinMOMarie-Laure OzouxinRORégis OlivierinFrancesca C. LawsonMark KowalaEJEleonore Jouannyin

Co-investorsFOFountain Healthcare PartnersJEJeito CapitalOROrbiMedV-V-Bio VenturesOMOmnes CapitalINInvivo Capital Partners+1 more

Damae Medical develops deepLive, a non-invasive skin imaging system based on LC-OCT (Line-field Confocal Optical Coherence Tomography) that produces 3D histology-like and confocal-like images of skin tissue.

Deep TechDigital HealthMedical Devices

ABAnaïs Barut(Co-founder & CEO)inDavid Siret(Co-founder & CTO)inArnaud Dubois(Co-founder & CSO)in

Co-investorsPAParis-Saclay Seed FundIDIdinvest PartnersPAPartech Ventures

Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases.

BiotechMedical DevicesZurich, CH

Co-investorsPUPureos BioventuresYSYsios CapitalADAdjuvant CapitalFRFresenius Medical Care VenturesVEVerve VenturesREredalpine

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesSingapore, SG

Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMSMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in

Co-investorsANAngelini VenturesBOBoehringer Ingelheim Venture FundCLClavystBioHIHighlight CapitalSESEEDS Capital

Raidium builds an AI-native PACS viewer embedding a vision-language foundation model to support radiologists across research and clinical work, including automated tumor measurement and lesion segmentation.

AI & Machine LearningDigital HealthMedical DevicesParis, FR

PHPaul Herent, M.D., Msc(Founder)inPHPaul Hérent(Co-Founder and CEO)inPMPierre Manceron(Co-Founder and CSO)inSSSebastian Schwarz(COO)inDBDamien Benard(CFO)in

Co-investorsGAGalion.exeNENewfund CapitalFOFounders FutureDEDebiopharm Innovation FundSTStartX

SciRhom is a biotech company developing first-in-class humanized antibodies against iRhom2, which regulates the enzyme TACE/ADAM17 to block pro-inflammatory signaling pathways.

BiotechDeep TechHealthtechMartinsried, DE

DJDr. Jens Ruhe(Co-founder, Managing Director & Chief Operating Officer)DMDr. Matthias Schneider(Co-founder & Chief Scientific Officer)DJDr. Jan Poth(Managing Director, Chief Executive Officer)DJDr. Jürgen Reeß(Chief Medical Officer)

Co-investorsANAndera PartnersHAHadean VenturesBABayern Kapital

Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.

BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR

AFAlain Fischer(Founding Scientist)

Co-investorsHAHadean VenturesBPBpifrancePOPontifax Venture CapitalSUSunstone CapitalV-V-Bio Ventures

Synendos is a biotech company developing selective endocannabinoid reuptake inhibitors targeting the endocannabinoid system to treat neuropsychiatric disorders.

BiotechDeep TechDigital HealthMental HealthBasel, CH

Prof. Jürg Gertsch(Founder)Dr. Andrea Chicca(Co-Founder & Chief Executive Officer)DSDr. Simon Russell(Co-Founder & Chief Commercial Officer)

Co-investorsYSYsios CapitalSUSunstone Capital

Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.

BiotechDeep TechMedical DevicesBerlin, DE

Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)

Co-investorsCRCreathor VenturesBOBoehringer Ingelheim Venture FundCOcoparionTHThuja CapitalAPApollo Health Ventures

Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

LDLuc Dochez(Chair and Founder)inJMJosh Mandel-Brehm(Co-Founder)in

Co-investorsDRDroia VenturesPUPureos BioventuresEQEQT Life SciencesSESeroba Life SciencesEUEurazeoIDIdinvest Partners+1 more

Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis.

BiotechHealthtechParis, FR

Co-investorsHEHealthCapNONovartis Venture FundRORoche Venture FundYSYsios CapitalCOColumbus Venture PartnersEUEurazeo+1 more

Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.

BiotechHealthtechMedical Devices

JEJack Elands(Founder & CEO)inXPXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJHJan H.M. Schellens(Chief Medical Officer)inTMThierry Menguy(VP & Head of CMC Operations)inJAJaime Arango(Chief Financial Officer)inPJPaul Jackson(Chief Operating Officer)in

Co-investorsAMaMoonRARA CapitalBPBpifranceANAndera PartnersANAngelini VenturesPOPontifax Venture Capital+1 more

A digital agency that designs and builds websites and web applications, including HTML invitations with form-based response management and help desk applications.

Marketing TechSaaS

Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.

BiotechHealthtechLongevityPhiladelphia, US

RKRaj Kannan(Executive Officer, Director)

BoardCNClaudio Nessi(Director)inIGIvan Gergel(Director)inJVJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)

Co-investorsANAndera PartnersAVAvego BioScience CapitalGLGlobal BioAccess FundJEJeito CapitalNENew Rhein Healthcare Investors, LLCSESeroba Life Sciences+2 more

Alveus Pharmaceuticals is a pharmaceutical development company specializing in niche generic and specialty pharmaceutical products through internal product development and late-stage licensing.

BiotechHealthtechMedical DevicesHyderabad, IN

Srinivasa RAO Vankayalapati(Director, Operations)

AM-Pharma develops ilofotase alfa, a recombinant alkaline phosphatase enzyme therapy, and is studying it as a treatment for adults with hypophosphatasia (HPP), a rare inherited metabolic bone disease.

BiotechHealthtech

Co-investorsANAndera PartnersYSYsios CapitalFOForbion

Co-investorsANAndera PartnersCTCTI Life Sciences Fund L.P.EQEQT Life SciencesLSLSP (Life Sciences Partners)SOSofinnova Partners

Co-investorsNENewfund Capital

Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.

AI & Machine LearningBiotech

RFRobert Friesen(Founder)in

Co-investorsBIBioGeneration VenturesEQEQT Life SciencesBOBOMCUCurie CapitalV-V-Bio Ventures

Axithra, a spin-off from Ghent University's Photonics Research Group and imec, develops an optics- and photonics-based platform for therapeutic drug monitoring that measures and monitors drug concentrations in blood at the point of care.

Deep TechDigital HealthHealthtechMedical Devices

Co-investorsIMimec.xpandQBQbic FundWHWhite FundWAWallonie Entreprendre

BioSerenity develops and manufactures CE- and FDA-approved electrophysiological medical devices, AI, and software to capture and analyze EEG, ECG, and PSG signals for diagnosing neurological and cardiac disorders.

AI & Machine LearningDigital HealthMedical DevicesTroyes, FR

VMVincent MarcelinMarc Frouinin

Co-investorsJOJolt Capital

Kiro is a digital health company that transforms healthcare data into actionable intelligence by analyzing a person's biological patterns over time.

AI & Machine LearningDigital HealthHealthtech

Cardiologs develops software that uses clinically validated AI and cloud technology to analyze ECGs and support cardiology diagnostics.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsISIsaiISISAI GestionPAParis-Saclay Seed Fund

Charles is a French telehealth platform offering online medical consultations and personalized treatment for conditions such as sexual health, weight loss, and hair loss.

Digital HealthHealthtechWellness & Fitness

Co-investorsACAccelHVHV CapitalSASalesforce Ventures

Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases.

BiotechDeep TechHealthtechLongevityMedical DevicesUtrecht, NL

PDPeter de Keizer(Founder and Managing Director)inTMTobias Madl(Head of Structural Biology, Scientific Co-founder)

Co-investorsCOCoastCapCUCurie CapitalKOKorify CapitalAPApollo Health VenturesROROM Utrecht Region

Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.

BiotechDeep TechHealthtechMedical DevicesParis, FR

Co-investorsFUFund+SESeroba Life SciencesV-V-Bio VenturesBPBpifranceINInvusNONovo Holdings+1 more

DNA Script develops enzymatic DNA synthesis technology, producing nucleic acids for research and biotech applications.

BiotechDeep TechHardwareParis, FR

TYThomas Ybert(Founder)inXGXavier Godronin

Co-investorsCOCoatue ManagementM M Ventures

Elkedonia is a biotech company developing a novel antidepressant treatment that targets intracellular neuroplasticity pathways rather than synaptic mechanisms, with the goal of providing rapid, long-lasting relief for depression patients.

BiotechDigital HealthMental Health

DCDelphine Charvin(Founding Chief Executive Officer & Board Director)inMRMélanie Rouillier(VP, Chief Operations Officer & Co-Founder)inJocelyne Caboche(President of the Scientific Advisory Board & Co-Founder)in

Co-investorsANAngelini VenturesCACARMA FUND

EVL Bio is developing a selective anti-FGFR4 monoclonal antibody therapy to treat left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD).

BiotechDigital HealthLongevity

Robert Kirmeier(Founder)inWenzel von der Heydte(Founder)in

Co-investorsADAdBio partners

Germitec develops UV-C technology-based disinfection systems for high-level decontamination of ultrasound probes and other medical devices used in healthcare settings.

Deep TechHardwareHealthtechMedical DevicesNot stated, FR

Co-investorsEUEuropean Investment BankEUEurazeo

Sunrise develops a wireless single-use sensor and companion iOS/Android app that records the respiratory signal at its source to detect sleep apnea at home in one night.

Digital HealthHealthtechMedical Devices

Hopia is an AI platform that automates staff scheduling for doctors and caregivers across all hospital departments, using a proprietary symbolic AI to model legal, collective, and individual rules.

AI & Machine LearningDigital HealthSaaS

MLMatthias Lesage(Founder)inVBVictoire Bach(Founder)in

Co-investorsIRIris Capital5050 Partners

ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.

BiotechHealthtech

Co-investorsAGAgent CapitalANAndera PartnersPFPfizer Venture InvestmentsPUPureos BioventuresALAlexandriaBPBpifrance+4 more

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

BiotechMedical Devices

Dr. Dhingra

Co-investorsAVAvoro Capital AdvisorsEIEIR VenturesRARA CapitalSASamsara BioCapitalSUSunstone CapitalVIVivo Capital+2 more

Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.

BiotechHealthtech

Co-investorsANAngelini VenturesCUCurie Capital

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops.

AgTechBiotechDeep Tech

Ricardo Garcia de Albain

Co-investorsGEGenoa VenturesSOSofinnova PartnersCACasdin Capital

Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.

BiotechDeep TechHealthtechMedical DevicesMataró, ES

MMMarc Martinell(Co-Founder & Chief Executive Officer)in

Co-investorsCHChiesi VenturesCRCriteria Bio VenturesFUFund+INInvivo Capital PartnersRORoche Venture FundYSYsios Capital+2 more

NAOX Technologies develops in-ear EEG technology to bring brain monitoring out of the lab and into everyday life.

HardwareHealthtechMedical Devices

Nuclidium develops copper-based radioligand therapeutics and diagnostics for cancer treatment and diagnosis, with programs targeting prostate and breast cancer using Copper-61 and Copper-67 isotopes.

BiotechDeep TechHealthtechMedical DevicesBasel, CH

Leila Jaafar(CEO)Gustav(Medical Advisor)

Co-investorsANAngelini VenturesDEDeepTech & Climate FondsNENeva Sgr.VIVIVES Partners

Omnidoc provides a medical collaboration platform for healthcare professionals and organizations, offering telexpertise (remote specialist advice), e-RCP (multidisciplinary team meetings), and assisted teleconsultation.

Digital HealthHealthtechSaaSParis, FR

BTBaptiste Truchot(Founder)in

Co-investorsNENewfund CapitalALAlven

PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.

BiotechDeep TechHealthtechMedical DevicesMol, BE

SVSven van den berghe(CEO)inCMChristophe Malice(CBO)inSamy Bertrand(CTO)inYSYves Sterckx(Director of Finance & Administration)inPhilippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)

Co-investorsEQEQT Life SciencesKOKorysLSLSP (Life Sciences Partners)PMPMV

PathoQuest develops iDTECT, a platform of Next Generation Sequencing (NGS) assays for biopharmaceutical quality control, offering animal-free viral safety testing and genetic characterization of cell banks and biologics.

BiotechDeep TechHealthtechMedical DevicesParis, FR

MEMarc Eloit(Founder and Scientific Advisor)in

Co-investorsVEVerve Ventures

Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema.

BiotechHealthtech

Co-investorsBABain Capital Life SciencesFOForesite CapitalVEvenBio Partners

Poppins operates a peer-to-peer rental marketplace where individuals, professionals, and local shops in the same neighborhood lend and rent everyday objects, with booking, owner messaging, and a guarantee system handled in one app.

Circular EconomyConsumerMarketplaces

LBLucie Basch(Cofondatrice)inFPFranco Prontera(Cofondateur)inJMJonas Mallisse(Cofondateur)in

Co-investorsAFAFI VenturesKIKima VenturesBNBNP Paribas DéveloppementEUEurazeoVEVerve Ventures

Poppins is a clinically validated digital medical device for children aged 7-11 with dyslexia and reading difficulties.

AI & Machine LearningDigital HealthEdTechHealthtechParis, FR

Co-investorsTETechstarsVEVerve Ventures

Recept AI provides an AI-powered virtual receptionist/tele-secretary service for dental practices, handling incoming calls, appointment booking, cancellations, reminders and patient record management 24/7.

AI & Machine LearningDigital HealthSaaS

RyCarma Therapeutics develops a novel drug class called Rycals to treat orphan skeletal muscle and cardiac diseases, building on foundational cardiovascular research and drug-delivery technologies.

BiotechHealthtechMedical DevicesNew York, US

ARAndrew R. Marks(Founding Scientist, MD)

Co-investorsPOPontifax Venture Capital

Sensome develops medical technology solutions at the intersection of engineering and life sciences, focusing on healthcare applications.

Deep TechHealthtechMedical Devices

Co-investorsPAParis-Saclay Seed FundBNBNP Paribas DéveloppementIDIdinvest Partners

Shorla Oncology develops pharmaceutical products to address unmet needs in oncology.

BiotechHealthtechMedical DevicesDublin, IE

SCSharon Cunningham(CEO & Co-Founder)inOrlaith Ryan(CTO & Co-Founder)in

Co-investorsSESeroba Life SciencesENEnterprise Ireland

SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring.

BiotechDeep TechHealthtechMedical DevicesPortola Valley, US

MARK DAHM(Executive Officer, Director)

BoardRICHARD DEATLEY(Director)ROBERT TERRY(Director)TJ DURNAN(Director)

Co-investorsM M Capital Partners

Spotlight Medical develops AI-enabled prognostic assays for cancer risk assessment, starting with myStage Dx, a test for early-stage ER+/HER2– breast cancer that helps clinicians identify low-risk patients within high-risk clinical groups.

AI & Machine LearningDigital HealthMedical Devices

SBSylvain Berlemont(Cofounder & Chief Executive Officer)inMarvin Lerousseau(Cofounder & Chief Scientific Officer)in

Co-investorsHEHeal Capital

Co-investorsILIllumina Ventures

Strategic Partners A/S is a Danish company listed on Nasdaq Copenhagen that enters into strategic partnerships with businesses of significant potential, taking active ownership to create value.

Sector Agnostic

Sunrise AI designs, deploys, and operates custom AI systems inside client businesses, connecting to their proprietary data and workflows to build an "AI operating layer" starting with a single high-impact workflow.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsAIAI Fund

San Francisco, US

Michael Barber(Director)Philip Dur(Executive Officer, Director)Ashmi Shah(Executive Officer)Dean Stephens(Executive Officer, Director)Shahyan Currimbhoy(Executive Officer)Niraj Katwala(Executive Officer)

Co-investorsKAKaiser Permanente VenturesVAVantagePoint Capital PartnersSUSummit Partners

VICO provides AI-generated forecasts and event risk ratings that track and triangulate analyst views into continuous time series data.

AI & Machine LearningData & InfrastructureFintech

Co-investorsAIAIN VenturesMUMultiball CapitalDRDroia VenturesEQEQT Life SciencesEUEurazeoPUPureos Bioventures